Catalyst Funds Management Pty Ltd

Position in MYGN — Myriad Genetics Inc

CIK 1896150 SYDNEY NSW, C3

Position in MYGN

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$152,910

+$74,638 QoQ

Shares Held

33,980

+961.9% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Catalyst Funds Management Pty Ltd holds $1,479,733 across 6 Diagnostics & Research names. MYGN ranks #5 (10.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MEDP	Medpace Holdings, Inc.	1,040	$499,397
2	VCYT	Veracyte, Inc.	8,700	$280,227
3	WAT	Waters Corp /De/	920	$273,976
4	DGX	Quest Diagnostics Inc	1,065	$208,718
5	MYGN	Myriad Genetics Inc This page	33,980	$152,910
6	MDXH	MDxHealth SA	28,046	$64,505

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$152,910	33,980	+961.9%	Shares	Sole	2026-05-11
2024-06-30	$78,272	3,200	—	Shares	Sole	2024-12-18
No filing history on record for this holder in this stock.